SCHEMBL18645166

SCHEMBL18645166

CC(=N)c1ccc2oc(C)nc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.50
GAA P10253 2/20 0.50
TAS1R3 Q7RTX0 4/20 0.46
TAS1R1 Q7RTX1 4/20 0.46
RAB9A P51151 4/20 0.46
NPC1 O15118 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
STAT1 P42224 1/20 0.46
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPT P10636 2/20 0.43
POLB P06746 1/20 0.43
CHRNA7 P36544 1/20 0.42
LMNA P02545 2/20 0.42
KLK3 P07288 1/20 0.39
EPHX2 P34913 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
MAPK1 P28482 2/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18645722 0.85 L3MBTL1 (0.49) L3MBTL1GAATAS1R3TAS1R1RAB9A
SCHEMBL18644549 0.83 GAA (0.50) L3MBTL1GAATAS1R3TAS1R1RAB9A
SCHEMBL20482131 0.83 RAB9A (0.56) L3MBTL1GAATAS1R3TAS1R1RAB9A
SCHEMBL701884 0.79 TDP1 (0.54) L3MBTL1GAATAS1R3TAS1R1RAB9A
SCHEMBL30041235 0.79 TDP1 (0.54) L3MBTL1GAATAS1R3TAS1R1RAB9A
SCHEMBL18644553 0.78 L3MBTL1 (0.49) L3MBTL1GAATAS1R3TAS1R1RAB9A
SCHEMBL13356595 0.78 RAB9A (0.51) L3MBTL1GAATAS1R3TAS1R1RAB9A
SCHEMBL9181228 0.76 TAS1R3 (0.58) L3MBTL1GAATAS1R3TAS1R1RAB9A
SCHEMBL27326882 0.76 TAS1R3 (0.58) L3MBTL1TAS1R3TAS1R1RAB9ANPC1
SCHEMBL1192488 0.74 ESR1 (0.58) L3MBTL1GAATAS1R3TAS1R1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017042182-A1 TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2017-03-16 WO disclosed